Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007)

Journal of the American Veterinary Medical Association

Volumn 233, Issue 12, 2008, Pages 1896-1901

  Lien, Yu Hsin ^a   Huang, Hui Pi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; KETOCONAZOLE;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; BLOOD; CONFERENCE PAPER; DOG; DOG DISEASE; ENDOCRINE FUNCTION TEST; FEMALE; MALE; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADRENAL CORTEX FUNCTION TESTS; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; DOG DISEASES; DOGS; FEMALE; HYDROCORTISONE; KETOCONAZOLE; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 58149147606     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.233.12.1896     Document Type: Conference Paper

References (29)

1. Reusch CE. Hyperadrenocorticism. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 6th ed. St Louis: Elsevier Inc, 2005;1592-1610.
2. Feldman EC, Nelson RW Canine hyperadrenocorticism. In: Feldman EC, Nelson RW, eds. Canine and feline endocrinology and reproduction. 3rd ed. St Louis: WB Saunders Co, 2004;252-357.
3. Barker EN, Campbell S, Tebb AJ, et al. A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2005;19:810-815.
4. Den Hertog E, Braakman JC, Teske E, et al. Results of nonselective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary dependent hyperadrenocorticism. Vet Rec 1999;144:12-17.
5. Randolph JF, Toomey J, Center SA, et al. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD). Am J Vet Res 1998;59:258-261.
6. Angles JM, Feldman EC, Nelson RW, et al. Use of urine Cortisol: creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitarydependent hyperadrenocorticism in dogs. J Am Vet Med Assoc 1997;211:1002-1004.
7. Dunn KJ, Herrtage ME, Dunn JK. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism. Vet Rec 1995;137:161-165.
8. Kintzer PP, Peterson ME. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991;5:182-190.
9. Rijnberk A, Belshaw BE. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism. Vet Rec 1988;122:486-488.
10. Feldman EC, Nelson RW, Feldman MS, et al. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs. J Am Vet Med Assoc 1992;200:1642-1647.
11. Lorenz MD. Diagnosis and medical management of canine Cushing's syndrome: a study of 57 consecutive cases. J Am Anim Hosp Assoc 1982;18:707-716.
12. Alenza DP, Arenas C, Lopez ML, et al. Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism. J Am Anim Hosp Assoc 2006;42:269-276.
13. Wenger M, Sieber-Ruckstuhl NS, Müller C, et al. Effect of trilostane on serum concentrations of aldosterone, Cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am J Vet Res 2004;65:1245-1250.
14. Braddock JA, Church DB, Robertson ID, et al. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Vet J 2003;81:600-607.
15. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506-512.
16. Neiger R, Ramsey I, O'Connor J, et al. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002;150:799-804.
17. Feldman EC, Bruyette DS, Nelson RW, et al. Plasma Cortisol response to ketoconazole administration in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1990;197:71-78.
18. Behrend EN, Kemppainen RJ, Clark TP, et al. Treatment of spontaneous hyperadrenocorticism in dogs: a survey of internists and dermatologists. J Am Vet Med Assoc 1999;215:938-943.
19. Hall EJ, Miller WH, Medleau L. Ketoconazole treatment of generalized dermatophytosis in a dog with hyperadrenocorticism. J Am Anim Hosp Assoc 1984;20:597-602.
20. Stolp R, Croughs RJ, Rijnberk A. Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1984;101:311-314.
21. Pérez AM, Guerrero B, Melián C, et al. Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog. J Small Anim Pract 2002;43:104-108.
22. Reusch CE, Steffen T, Hoerauf A. The efficacy of L-deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1999;13:291-301.
23. De Coster R, Beerens D, Dom J, et al. Endocrinological effects of single daily ketoconazole administration in male beagle dogs. Acta Endocrinol (Copenh) 1984;107:275-281.
24. Willard MD, Nachreiner R, McDonald R, et al. Ketoconazole-induced changes in selected canine hormone concentrations. Am J Vet Res 1986;47:2504-2509.
25. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocr Rev 1993;14:443-458.
26. Legendre AM, Selcer BA, Edwards DF, et al. Treatment of canine blastomycosis with amphotericin B and ketoconazole. J Am Vet Med Assoc 1984;184:1249-1254.
27. Kintzer PP, Peterson ME. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. J Am Vet Med Assoc 1994;205:54-61.
28. De Coster R, Coene MC, Haelterman C, et al. Effects of high-dose ketoconazole treatment on adrenal mineralocorticoid biosynthesis in dogs and rats. Acta Endocrinol (Copenh) 1987;115:423-431.
29. Chapman PS, Kelly DF, Archer J, et al. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism. J Small Anim Pract 2004;45:307-310.